Conjunctival cytokine expression in symptomatic moderate dry eye subjects

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2445-2450

  Narayanan, Srihari ^a   Miller, William L ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPHRIN A5; FLUORESCEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; INTERLEUKIN 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CLEARANCE; COMPARATIVE STUDY; CONJUNCTIVA; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CYTOLOGY; DRY EYE; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; FLUOROPHOTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LACRIMAL FLUID; MALE; MODULATION; ONCOGENE; OSMOLALITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SCORING SYSTEM; SYMPTOM; UPREGULATION; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; CELLS, CULTURED; CONJUNCTIVA; CYTOKINES; DRY EYE SYNDROMES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TEARS; UP-REGULATION;

EID: 33745672352     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1364     Document Type: Article

References (42)

1. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
2. Narayanan S, Miller WL, Prager TC, et al. The diagnosis and characteristics of moderate dry eye in non-contact lens wearers. Eye Contact Lens. 2005;31:96-104.
3. Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46-50.
4. Caffery BE. Influence of diet on tear function. Optom Vis Sci. 1991;68:58-72.
5. Maumenee AE, Stark WJ, Maumenee IH, Jensen AD, Green WR. Topical retinoid treatment for various dry-eye disorders. Ophthalmology. 1989;96:730.
6. Soong HK, Martin NF, Wagoner MD, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders: a multicenter, placebo-controlled double-masked study. Ophthalmology. 1988;95:1442-1446.
7. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res. 1998;17:565-596.
8. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19:644-649.
9. Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alterations of ocular surface gene expression in Sjogren's syndrome. Adv Exp Med Biol. 1998;438:533-536.
10. Gilbard JP, Farris RL. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol. 1979;97:1642-1646.
11. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96:677-681.
12. Sullivan DA, Wickham LA, Rocha EM, et al. Androgens and dry eye in Sjogren's syndrome. Ann N Y Acad Sci. 1999;876:312-324.
13. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
14. Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506-2512.
15. Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868-1874.
16. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
17. Lemp MA. Epidemiology and classification of dry eye. Adv Exp Med Biol. 1998;438:791-803.
18. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609-2614.
19. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356-1363.
20. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial: the Cyclosporin A Phase 2 Study Group. Ophthalmology. 2000;107:967-974.
21. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136:593-602.
22. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology. 1999;106:811-816.
23. Turner K, Pflugfelder SC, Ji Z, et al. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000;19:492-496.
24. Narayanan S, Miller WL, McDermott AM. Expression of human β-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci. 2003;44:3795-3801.
25. McDermott AM, Redfern RL, Zhang B, et al. Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:1859-1865.
26. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483-490.
27. Raj PA, Dentino AR. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett. 2002;206:9-18.
28. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
29. Wilson SE, Mohan RR, Ambrosio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20:625-637.
30. Mahajan VB, Wei C, McDonnell PJ 3rd. Microarray analysis of corneal fibroblast gene expression after interleukin-1 treatment. Invest Ophthalmol Vis Sci. 2002;43:2143-2151.
31. Narayanan S, Glasser A, Hu Y-S, McDermott AM. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells. Exp Eye Res. 2005;80:175-183.
32. Yamagami H, Yamagami S, Inoki T, Amano S, Miyata K. The effects of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci. 2003;44:514-520.
33. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18:293-309.
34. Korb DR, Greiner JV, Herman J. Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method. Cornea. 2001;20:811-815.
35. Diebold Y, Calonge M, Enriquez de Salamanca A, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003;44:4263-4274.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
37. Pflugfelder SC, Solomon A, Dursun D, Li DQ. Dry eye and delayed tear clearance: "a call to arms." Adv Exp Med Biol. 2002;506:739-743.
38. Oates AC, Lackmann M, Power MA, et al. An early developmental role for eph-ephrin interaction during vertebrate gastrulation. Mech Dev. 1999;83:77-94.
39. Matsumura R, Umemiya K, Kagami M, et al. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjogren's syndrome. Clin Exp Rheumatol. 2002;20:791-798.
40. Stahl JL, Cook EB, Graziano FM, Barney NP. Differential and cooperative effects of TNFα, IL-1β, and IFNγ on human conjunctival epithelial cell receptor expression and chemokine release. Invest Ophthalmol Vis Sci. 2003;44:2010-2015.
41. Paolieri F, Battifora M, Riccio AM, et al. Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines. Allergy. 1997;52:521-531.
42. Gamache DA, Dimitrijevich SD, Weimer LK, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm. 1997;5:117-128.